US6775569B2
(en)
*
|
1997-11-05 |
2004-08-10 |
Hisamitsu Pharmaceutical Co., Inc. |
Electroporation device for in vivo delivery of therapeutic agents
|
US6757560B1
(en)
*
|
1999-04-09 |
2004-06-29 |
Novosis Pharma Ag |
Transdermal delivery system (TDS) with electrode network
|
CA2337129A1
(en)
|
1998-07-13 |
2000-01-20 |
Genetronics, Inc. |
Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications
|
US7922709B2
(en)
*
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
US6192270B1
(en)
*
|
1998-08-14 |
2001-02-20 |
Genetronics, Inc. |
Apparatus and method for the delivery of drugs and genes into tissue
|
US7171264B1
(en)
*
|
1999-05-10 |
2007-01-30 |
Genetronics, Inc. |
Intradermal delivery of active agents by needle-free injection and electroporation
|
US8209006B2
(en)
*
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
US7245963B2
(en)
*
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
US8016810B2
(en)
*
|
2003-06-23 |
2011-09-13 |
Transpharma Medical Ltd. |
Transdermal delivery system for cosmetic agents
|
AU2005289828A1
(en)
|
2004-09-24 |
2006-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and devices for the non-thermal, electrically-induced closure of blood vessels
|
ES2278499B1
(en)
*
|
2005-06-10 |
2008-07-16 |
Narciso Barbero Castro |
Device for generating electro-osmosis, comprises unit to generate high voltage, other unit to electric field from high voltage and third unit to apply electric field on surface of membrane to produce osmosis effect
|
ATE466537T1
(en)
*
|
2006-01-03 |
2010-05-15 |
Alcon Inc |
SYSTEM FOR CLIVING AND REMOVAL OF PROTEINOUS TISSUE
|
US20070185431A1
(en)
*
|
2006-02-03 |
2007-08-09 |
Kern Dale G |
Galvanic Current Skin Treatment
|
EP1981581B1
(en)
*
|
2006-02-11 |
2016-04-13 |
Genetronics, Inc. |
Device for single-needle in vivo electroporation
|
HUP0600444A2
(en)
*
|
2006-05-29 |
2007-11-28 |
Istvan Magyar |
Microcurrent therapy device
|
US7996077B2
(en)
*
|
2006-09-06 |
2011-08-09 |
Encore Medical Asset Corporation |
Iontophoresis apparatus and method
|
DK2066399T3
(en)
|
2006-10-17 |
2019-01-21 |
Inovio Pharmaceuticals Inc |
Electroporation devices and methods for using them for the electroporation of cells in mammals
|
US20080188791A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Difiore Attilio E |
Active iontophoresis delivery system
|
US8197844B2
(en)
*
|
2007-06-08 |
2012-06-12 |
Activatek, Inc. |
Active electrode for transdermal medicament administration
|
US8862223B2
(en)
|
2008-01-18 |
2014-10-14 |
Activatek, Inc. |
Active transdermal medicament patch and circuit board for same
|
US8718778B2
(en)
*
|
2008-04-15 |
2014-05-06 |
Research Foundation Of The City University Of New York |
Apparatus and method for neurocranial electrostimulation
|
US20110118729A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Alcon Research, Ltd |
High-intensity pulsed electric field vitrectomy apparatus with load detection
|
US20110118734A1
(en)
*
|
2009-11-16 |
2011-05-19 |
Alcon Research, Ltd. |
Capsularhexis device using pulsed electric fields
|
US20110135626A1
(en)
*
|
2009-12-08 |
2011-06-09 |
Alcon Research, Ltd. |
Localized Chemical Lysis of Ocular Tissue
|
US20110144562A1
(en)
*
|
2009-12-14 |
2011-06-16 |
Alcon Research, Ltd. |
Localized Pharmacological Treatment of Ocular Tissue Using High-Intensity Pulsed Electrical Fields
|
WO2011081897A1
(en)
*
|
2009-12-15 |
2011-07-07 |
Alcon Research, Ltd. |
High-intensity pulsed electric field vitrectomy apparatus
|
DE102010024558B4
(en)
*
|
2010-06-22 |
2016-04-21 |
Amw Gmbh |
Transdermal therapeutic system with electrodes
|
US8546979B2
(en)
|
2010-08-11 |
2013-10-01 |
Alcon Research, Ltd. |
Self-matching pulse generator with adjustable pulse width and pulse frequency
|
US20120076808A1
(en)
|
2010-09-27 |
2012-03-29 |
China Agricultural University |
Combined antigen and dna vaccine for preventing and treating autoimmune diseases
|
US8428709B1
(en)
*
|
2012-06-11 |
2013-04-23 |
Incline Therapeutics, Inc. |
Current control for electrotransport drug delivery
|
US8428708B1
(en)
|
2012-05-21 |
2013-04-23 |
Incline Therapeutics, Inc. |
Self-test for analgesic product
|
USD733899S1
(en)
|
2011-09-30 |
2015-07-07 |
Nse Products, Inc. |
Skin treatment device
|
CN103239734B
(en)
|
2012-02-10 |
2016-02-24 |
北京艾棣维欣生物技术有限公司 |
For preventing and/or treating the vaccine of respiratory syncytial virus infection
|
AU2013358947B2
(en)
|
2012-12-13 |
2016-10-20 |
Inovio Pharmaceuticals, Inc. |
WT1 vaccine
|
US10392611B2
(en)
|
2013-05-30 |
2019-08-27 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
US10364451B2
(en)
|
2013-05-30 |
2019-07-30 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
WO2014194244A1
(en)
|
2013-05-30 |
2014-12-04 |
Duke University |
Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates
|
CA2926025A1
(en)
|
2013-10-07 |
2015-04-16 |
The Trustees Of The University Of Pennsylvania |
Vaccines with interleukin-33 as an adjuvant
|
WO2015070027A1
(en)
|
2013-11-07 |
2015-05-14 |
University Of Southern California |
Use of ikk epsilon inhibitors to activate nfat and t cell response
|
US20160256539A1
(en)
|
2013-11-14 |
2016-09-08 |
The Trustees Of The University Of Pennsylvania |
HIV-1 ENV DNA Vaccine Plus Protein Boost Delivered by EP Expands B- and T-Cell Response and Neutralizing
|
AU2014354797C1
(en)
|
2013-11-29 |
2018-02-01 |
Inovio Pharmaceuticals, Inc. |
MERS-CoV vaccine
|
US10835595B2
(en)
|
2014-01-06 |
2020-11-17 |
The Trustees Of The University Of Pennsylvania |
PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy
|
US10772473B2
(en)
|
2014-08-13 |
2020-09-15 |
Nse Products, Inc. |
Device and method for cleansing and treating skin
|
WO2016025702A1
(en)
|
2014-08-13 |
2016-02-18 |
Nse Products, Inc. |
Device and method for cleansing and treating skin
|
JP6737778B2
(en)
|
2014-10-01 |
2020-08-12 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Vaccine with antigen and interleukin-21 as adjuvant
|
WO2016123285A1
(en)
|
2015-01-29 |
2016-08-04 |
The Trustees Of The University Of Pennsylvania |
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
|
WO2016154530A1
(en)
|
2015-03-26 |
2016-09-29 |
Duke University |
Targeted therapeutic agents comprising multivalent protein-biopolymer fusions
|
JP6882782B2
(en)
|
2015-08-04 |
2021-06-02 |
デューク ユニバーシティ |
Genetically encoded, essentially chaotic delivery stealth polymers and how to use them
|
USD782197S1
(en)
*
|
2015-08-13 |
2017-03-28 |
Nse Products, Inc. |
Treatment brush head
|
USD829445S1
(en)
*
|
2015-08-13 |
2018-10-02 |
Nse Products, Inc. |
Treatment brush head
|
USD778066S1
(en)
*
|
2015-08-13 |
2017-02-07 |
Nse Products, Inc. |
Treatment brush head
|
US20190015520A1
(en)
|
2015-12-21 |
2019-01-17 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
WO2017173398A1
(en)
|
2016-04-01 |
2017-10-05 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
CN109415714A
(en)
|
2016-04-29 |
2019-03-01 |
艾诺奥医药品有限公司 |
Enhance the delivering of medicament using chondroitinase and/or hyaluronidase in vivo
|
US11467156B2
(en)
|
2016-06-01 |
2022-10-11 |
Duke University |
Nonfouling biosensors
|
US10233419B2
(en)
|
2016-06-30 |
2019-03-19 |
Zymergen Inc. |
Apparatuses and methods for electroporation
|
CN109890833A
(en)
|
2016-09-14 |
2019-06-14 |
杜克大学 |
The nanoparticle based on three block polypeptide for delivery of hydrophilic drug
|
KR20190064600A
(en)
|
2016-09-23 |
2019-06-10 |
듀크 유니버시티 |
Unstructured non-repetitive polypeptides with LCST behavior
|
US10376495B2
(en)
|
2016-11-23 |
2019-08-13 |
University Of South Florida |
Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
US10813935B2
(en)
|
2017-02-23 |
2020-10-27 |
Transgenex Nanobiotech, Inc. |
Methods and compositions for treating drug resistance in cancer
|
US10272052B2
(en)
|
2017-02-24 |
2019-04-30 |
University Of South Florida |
Compositions and methods for the treatment of tauopathies
|
WO2018156989A1
(en)
|
2017-02-24 |
2018-08-30 |
University Of South Florida |
The hsp90 activator aha1 drives production of pathological tau aggregates
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
JP2020521528A
(en)
|
2017-05-25 |
2020-07-27 |
エヌエスイー プロダクツ インコーポレイテッド |
TENS attachment for equipment to clean and treat skin
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
Order and disorder as a design principle for stimuli-responsive biopolymer networks
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
RU2705104C2
(en)
*
|
2017-10-17 |
2019-11-05 |
Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Дагестанский Государственный Технический Университет" (Дгту) |
Thermoelectric device for performing electrophoretic treatment procedures
|
JP6964235B2
(en)
*
|
2018-01-17 |
2021-11-10 |
パナソニックIpマネジメント株式会社 |
Drug infiltration device
|
EP3829622A4
(en)
|
2018-08-02 |
2022-05-11 |
Duke University |
Dual agonist fusion proteins
|
RU2709159C1
(en)
*
|
2018-10-26 |
2019-12-16 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Владимирский Государственный Университет имени Александра Григорьевича и Николая Григорьевича Столетовых" (ВлГУ) |
Device for treating fungal infections of nails
|
WO2020209961A1
(en)
|
2019-04-08 |
2020-10-15 |
Udayan Patel |
Inflatable balloon over catheter with bypass passageway
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
MX2022010460A
(en)
|
2020-02-25 |
2022-09-19 |
Inovio Pharmaceuticals Inc |
Vaccines against coronavirus and methods of use.
|
USD933840S1
(en)
|
2020-04-21 |
2021-10-19 |
Nse Products, Inc. |
Microcurrent skin treatment device
|
IL297903A
(en)
|
2020-05-14 |
2023-01-01 |
Inovio Pharmaceuticals Inc |
Vaccines for recurrent respiratory papillomatosis and methods of using the same
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
EP4165183A1
(en)
|
2020-06-12 |
2023-04-19 |
University of Rochester |
Encoding and expression of ace-trnas
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
WO2022238789A1
(en)
*
|
2021-05-12 |
2022-11-17 |
Cochlear Limited |
Electroporation gene therapy for tissue barriers
|
WO2023057567A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
WO2023057946A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Serum half-life extended pd-l1 binding polypeptides
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|